Edition:
United States

Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

4.67USD
18 Aug 2017
Change (% chg)

$-0.21 (-4.30%)
Prev Close
$4.88
Open
$4.83
Day's High
$4.86
Day's Low
$4.66
Volume
1,489,155
Avg. Vol
1,761,660
52-wk High
$9.49
52-wk Low
$3.15

Select another date:

Mon, Jul 10 2017

BRIEF-Achillion Pharmaceuticals says Joel Barrish plans to leave co

* Achillion Pharmaceuticals Inc - ‍announced that Joel Barrish, executive vice president and chief scientific officer, plans to leave company

BRIEF-Achillion Q1 loss per share $0.15

* Achillion reports first quarter 2017 financial results and provides update on clinical programs

BRIEF-Achillion announces initiation of patient dosing in phase 2 study of ACH-4471

* Achillion announces initiation of patient dosing in phase 2 study of ACH-4471 for paroxysmal nocturnal hemoglobinuria

BRIEF-Achillion Pharmaceuticals to support a natural history study of C3 glomerulopathy

* Achillion Pharmaceuticals to support a natural history study of C3 glomerulopathy, a rare renal disorder, conducted by experts at Imperial College London Source text for Eikon: Further company coverage:

BRIEF-Achillion Pharmaceuticals Inc says files for mixed shelf of upto $250 million

* Achillion Pharmaceuticals Inc says files for mixed shelf of upto $250 million - SEC filing Source text for Eikon: (http://bit.ly/2l58Pa8) Further company coverage:

BRIEF-Achillion Pharmaceuticals Q4 revenue $15 million

* Achillion reports 2016 fourth quarter and year-end financial results

Select another date: